Cytomegalovirus (CMV) continues to have a tremendous impact in solid organ
transplantation despite remarkable advances in its diagnosis, prevention and treatment. It …

Investigations over the past two decades are revealing complexities in the regulation of the
innate immune response, and how this response, in turn, controls adaptive immunity …

Biliary complications (BCs) remain one of the most outstanding factors influencing long-term
results after orthotopic liver transplantation. The authors carried out a systematic overview of …

Maribavir is an oral benzimidazole riboside with potent in vitro activity against
cytomegalovirus (CMV), including some CMV strains resistant to ganciclovir. In a …

Objective This study was performed to identify risk factors for acute cellular rejection after
liver transplantation (LT). Methods Consecutive LT recipients who underwent surgery in our …

Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are human herpesviruses (HHV) that
are common in humans. Primary EBV and CMV infections mostly are asymptomatic but can …

The liver contains approximately one-third of the reticuloendothelial system mass in
humans. As the recipient of both the portal and systemic circulation, the liver plays an …

The majority of patients who undergo liver transplantation (LT) spend some time in the
intensive care unit during the postoperative period. For some, this is an expected part of the …

Congenital cytomegalovirus (CMV) infection is the most common infectious cause of
disability in newborn infants. CMV also causes serious disease in solid organ (SOT) and …

Background An immune function assay shows promise for identifying solid organ recipients
at risk for infection or rejection. The following randomized prospective study was designed to …